Browsing Tag
NASDAQ
352 posts
Luminar Technologies enters Chapter 11 as LiDAR pioneer seeks strategic buyers for core technology
Find out why Luminar Technologies entered Chapter 11 and how a court-supervised sale could reshape the future of its LiDAR and semiconductor technology.
December 15, 2025
iRobot (NASDAQ: IRBT) enters chapter 11 with Picea takeover as liquidity collapse forces balance sheet reset
iRobot Corporation enters chapter 11 as supplier Picea acquires the company, wiping out equity and resetting its balance sheet. Read what happens next.
December 15, 2025
Karbon Capital Partners raises $345m in SPAC IPO with energy-AI strategy in focus
Karbon Capital’s $345M SPAC IPO targets energy infrastructure deals tied to AI and LNG growth. Find out what this means for investors and industry players.
December 14, 2025
Mercado Libre and Agility Robotics strike landmark humanoid robot deployment deal for e-commerce fulfillment
Find out how Mercado Libre, Inc. is deploying Agility Robotics’ humanoid robots to reshape fulfillment logistics and what it could mean for future e-commerce operations.
December 10, 2025
At-home 12-lead ECG now a reality after FDA greenlights HeartBeam’s cable-free technology
Discover how HeartBeam’s FDA-cleared cable-free 12-lead ECG brings hospital-grade heart monitoring into homes and what it means for patients and investors.
December 10, 2025
Can Heidrick & Struggles’ $1.3bn buyout fuel its global leadership ambitions?
Heidrick & Struggles goes private in a $1.3 billion Advent–Corvex deal. Find out how this move could reshape global talent advisory.
December 10, 2025
How Lobo Technologies’ first German order for an EEC-certified electric tricycle could drive its EV growth narrative
Find out how Lobo Technologies’ first EEC-certified tricycle order in Germany could reshape its European electric mobility expansion strategy.
December 10, 2025
Moleculin hits key inflection point as pivotal MIRACLE Phase 3 AML trial completes treatment for first 45 patients
Find out how Moleculin Biotech’s pivotal MIRACLE Phase 3 milestone for Annamycin could reshape treatment for relapsed AML as Q1 2026 data approaches.
December 9, 2025
Pioneer Power Solutions introduces PRYMUS to cut AI data center power timelines from years to months
Learn how Pioneer Power Solutions’ PRYMUS fast-deploy power platform is reshaping AI data center timelines and what it means for infrastructure investors.
December 9, 2025
FDA grants RMAT designation to Senti Biosciences’ SENTI-202 after strong early AML trial results
Discover how Senti Biosciences’ SENTI-202 earned FDA RMAT designation after strong AML trial data and what it means for patients and investors.
December 9, 2025